Aclaris Therapeutics Inc. (ACRS)
undefined
undefined%
At close: undefined
3.05
-5.43%
After-hours Dec 13, 2024, 07:58 PM EST

Aclaris Therapeutics Inc. Forcast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for ACRS stock have an median target of 7, with a low estimate of 7 and a high estimate of 8. The median target predicts an increase of 116.72% from the current stock price of 3.23.

Analyst Consensus: Buy
Target Low Average Median High
Price $7 $7.33 $7 $8
Change 116.72% 126.93% 116.72% 147.68%

AI Analyst Report

Leerink Partners has upgraded Aclaris Therapeutics... Unlock content with Pro Subscription

Updated Nov 19, 2024

Rating Dec 23Jan 24Jul 24Aug 24Sep 24Nov 24
Strong Buy 000001
Buy 100003
Hold 121110
Sell 000000
Strong Sell 000000
Total 2 2 1 1 1 4

Financial Forecast this Year

Revenue This Year
8.45M
from 31.25M
Increased by -73%
Revenue Next Year
9.75M
from 8.45M
Increased by 15.4%
EPS This Year
-0.55
from -1.27
Increased by 56.7%
EPS Next Year
-0.6
from -0.55
Increased by -9.1%